Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Does therapy targeting normal SBP of less than 120 mm Hg reduce major CV events in T2DM patients?

Does therapy targeting normal SBP of less than 120 mm Hg reduce major CV events in T2DM patients? Curr Diab Rep. 2011 Aug; 11(4):233-5.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.